NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...
HB Wealth Management LLC lifted its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 49.2% during the fourth quarter, HoldingsChannel reports. The firm owned 8,149 shares ...
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...